2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors

Journal of Medicinal Chemistry
H O KimK A Jacobson


Adenosine derivatives bearing an N6-(3-iodobenzyl) group, reported to enhance the affinity of adenosine-5'-uronamide analogues as agonists at A3 adenosine receptors (J. Med. Chem. 1994, 37, 636-646), were synthesized starting from methyl beta-D-ribofuranoside in 10 steps. Binding affinities at A1 and A2a receptors in rat brain membranes and at cloned rat A3 receptors from stably transfected CHO cells were compared. N6-(3-Iodobenzyl)adenosine was 2-fold selective for A3 vs A1 or A2a receptors; thus it is the first monosubstituted adenosine analogue having any A3 selectivity. The effects of 2-substitution in combination with modifications at the N6- and 5'-positions were explored. 2-Chloro-N6-(3-iodobenzyl)adenosine had a Ki value of 1.4 nM and moderate selectivity for A3 receptors. 2-Chloro-N6-(3-iodobenzyl)adenosine- 5'-N-methyluronamide, which displayed a Ki value of 0.33 nM, was selective for A3 vs A1 and A2a receptors by 2500- and 1400-fold, respectively. It was 46,000-fold selective for A3 receptors vs the Na(+)-independent adenosine transporter, as indicated in displacement of [3H]N6-(4- nitrobenzyl)-thioinosine binding in rat brain membranes. In a functional assay in CHO cells, it inhibited adenylate cyclase via rat A3 re...Continue Reading


Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Q Y ZhouO Civelli
Dec 1, 1989·Journal of Molecular Recognition : JMR·K A JacobsonG L Stiles
Sep 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·U Schwabe, T Trost
Jul 1, 1982·Journal of Neurochemistry·P J MarangosA M Martino
Mar 4, 1994·Journal of Medicinal Chemistry·C Gallo-RodriguezP J van Galen
Mar 2, 1994·Biochemical Pharmacology·L E Brackett, J W Daly
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C A SalvatoreR G Johnson
May 1, 1993·British Journal of Pharmacology·J R Fozard, A M Carruthers

❮ Previous
Next ❯


Oct 1, 1995·Bioorganic & Medicinal Chemistry·S M SiddiqiK A Jacobson
Jun 5, 2002·European Journal of Pharmacology·Zhan-guo Gao, Kenneth A Jacobson
Dec 4, 2002·European Journal of Pharmacology·Sidney R SmithCarol Terminelli
Aug 1, 1998·European Journal of Pharmacology·S SatohO Hayaishi
Mar 17, 1999·European Journal of Pharmacology·D K Von LubitzK A Jacobson
Aug 31, 2001·Pharmacology, Biochemistry, and Behavior·C M KnappC Kornetsky
Apr 4, 2003·Behavioural Brain Research·Andrzej RubajMaria Sieklucka-Dziuba
Mar 6, 2003·Bioorganic & Medicinal Chemistry Letters·Moo Hong LimLak Shin Jeong
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J P MogensenL J Knutsen
Jul 29, 1998·Bioorganic & Medicinal Chemistry·S A Poulsen, R J Quinn
Mar 18, 2005·Journal of Medicinal Chemistry·Susanna TchilibonKenneth A Jacobson
Apr 4, 2012·Journal of Medicinal Chemistry·Pier Giovanni BaraldiKatia Varani
Jun 8, 2000·Journal of Medicinal Chemistry·K A JacobsonR G Ravi
Apr 12, 2008·Nucleosides, Nucleotides & Nucleic Acids·Moon Woo ChunLak Shin Jeong
Feb 22, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zhoumou ChenDaniela Salvemini
Jul 29, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tulasi R JinkaKelly L Drew
Jul 11, 2001·Journal of Molecular and Cellular Cardiology·V ShneyvaysA Shainberg
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·B T Liang, K A Jacobson
Mar 7, 2014·Purinergic Signalling·Chi Ting LeungMortimer M Civan
Sep 19, 2007·Expert Opinion on Emerging Drugs·Zhan-Guo Gao, Kenneth A Jacobson
Nov 14, 2006·Experimental Cell Research·Marina HermesDoris Kloor
Mar 26, 2002·Biochemical Pharmacology·Seong Gon KimKenneth A Jacobson
Oct 19, 2016·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kenneth A Jacobson, Mortimer M Civan

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.